Aim: To report the frequency of oral lesions in HIV-positive patients on Highly Active Antiretroviral Therapy (HAART), comparing with a non-HIV infected control group, and to correlate the presence of lesions with demographic and clinical features of HIV-seropositive patients. Methods: A quantitative case-control study was conducted by a dental professional, using a questionnaire, analysis of medical records of patients and clinical examinations. Results: According to the results, oral lesions were found in 23% of HIV-positive patients versus 5% in controls. Candidiasis (29%) and periodontal changes (25%) were the most frequent oral lesions found in these patients. Gender and viral load values were statistically significant when HIV-positive patients with and without oral lesions were compared. Conclusions: The results showed a change in lesion pattern of HIV patients on HAART, highlighting a high frequency of these new lesions and reinforcing the need for periodic dental evaluation of HIV-positive patients.
Introduction
AIDS has been a serious worldwide public health threat, with a global prevalence in 2010 of about 34 million and an overall number of AIDS-related deaths of 1.8 million of people. In Brazil up to the end of 2011, 608,200 cases were notified, 397,662 (65.4%) in males and 210,538 (34.6%) in females. Currently, investments in prevention, scaling up access to HIV testing and to antiretroviral treatment, as well as training of health professionals, keep the AIDS epidemic under control 1 . According to the Brazilian Ministry of Health, the prevalence of the disease in 2011 remained stable at around 0.6%, while the incidence was 17.9/100,000 inhabitants. In the state of Paraná, Southern Brazil, 32,273 cases were reported in the same period, with an incidence of 19/100,000 inhabitants. The Southern region ranks third in the number of AIDS cases in Brazil, with 21.1% of cases, after the Southeast (38.2%) and Northeast (21.7%). Nevertheless, this is the region where the largest number of new cases were detected in 2009, with a detection rate of 12.6/100,000 inhabitants 1 . Oral manifestations are frequently seen during the course of the disease and can be symptoms of early HIV infection. With their immune system severely compromised by HIV infection, patients are vulnerable to opportunistic infections and cancers, particularly oral lesions such as oral candidiasis, Kaposi's sarcoma, sores, gingivitis, periodontitis and herpes lesions. The emergence of these lesions is associated with immunodeficiency, and they are often the first symptom of AIDS or an indication of worsening of disease. HIV patients with associated oral lesions often complain of chewing problems, burning sensation, and difficulty in swallowing and speech among others, which has a negative impact on their quality of life [2] [3] [4] . A wide spectrum of oral manifestations may occur in these patients dependent on factors such as degree of immune impairment, use of antiretroviral therapy, oral hygiene, among others 5 . Since these oral manifestations associated to the progression of HIV infection are common and may be the first clinical signs of disease, the dentist has a very important role in detecting and diagnosing the disease in its earliest stages and in providing appropriate treatment to the patient 6 . Oral manifestations in HIV-positive patients have been the subject of many studies in the pre-HAART era. These studies have become less frequent after the introduction of the HAART. The aims of this study are to report the frequency of oral lesions in HIV patients on HAART, compared with a non-HIV infected control group and correlate the lesion with demographic and clinical features of HIV-seropositive patients. 
Material and methods

Study Design
Casuistic
The HIV-positive patients and a control group were included in the study after providing written informed consent. A questionnaire was used to collect clinical data based on the analysis of the medical records, obtain demographic and behavioral information provided by the patient and report clinical examinations performed by one dentist using a visual examination method.
To select the control group, the authors conducted a search on clinics that offered free dental treatment, such as clinics of trade unions for care workers, which presented socioeconomic level and educational instruction similar to the HIV-positive patients. Subjects were randomly invited to participate in the study, and those who accepted and signed the informed consent were examined. From 596 individuals analyzed, 208 that met the criteria for median age similar to the patients of the study groups and previous negative HIV antibody test within 6 months were included as controls. The questionnaire applied to this group was similar to the one used in the study group.
Sample Size Calculation
Sample size calculation was based on the following estimates: α error of 0.05; β error= 0.20 (80% power). For the purposes of these calculations the prevalence of oral lesion in HIV+ patients was arbitrarily set at 15% and in control group at 5%. Considering that the number of HIV+ treated at this hospital is around 1,000, the finite population correction factor was used to reduce the standard error. Incorporating these estimates into the equation yields a sample size of 164, assuming a 20% loss, at least 197 were required per group.
Statistical analysis
Descriptive analysis was performed for all variables. Data were compiled using the JMP software version 5.2.1 and analyzed by the GraphPad Prism software version 5.03. Fisher's exact or÷2 tests were used to assess differences between groups and Mann Whitney test was used for continuous variables, as appropriate. Results of continuous data are expressed as median ± interquartile range (IQR). All P-values were two-tailed and a value of <0.05 was considered significant.
Results
A total of 241 HIV-positive patients and 208 control individuals were enrolled in the study. The control group showed a similar profile to the study group with relation to age and years of education. The median age of the patients was 41 and 36 years for HIV-positive and control group, respectively, and 63% of HIV-positive individuals and 60% of controls had between 4 and 11 years of education. Other demographic and epidemiological findings are shown in Table 1 .
HIV-positive patients had been diagnosed with HIV infection for an average of 8.4 (±4.9) years and presented a median of nadir and current CD4+T lymphocyte count of 276.5 cells/mm 3 (IQR, 123.3-502.3) and 426 cells/mm 3 (IQR, 264-630), respectively. Most patients (78.6%) were on HAART and in 167 cases (69%) viral load was undetectable. Among those with detectable viral load, the median was 3,737 copies/mL (IQR 558 -26,267), 20.3% had <10,000 copies/ mL, 7% had between 10,000 and 100,000 copies/mL, and only 2.9% of patients had more than 100,000 copies/mL.
Oral lesions were found in 56/241 (23%) of HIV-positive patients versus 10/208 (5%) in controls (p<0.001). As shown in Figure 1 , the most frequent lesions in HIV-positive patients were candidiasis and periodontal changes, while herpes lesions were more common in the control group, which was found in 3.5% (2/56) of HIV-positive patients and in 80% (8/10) of control group. Idiopathic white patch and ulcerations of oral mucosa were observed in 23% and 5% of HIV-positive patients, respectively.
Comparison between HIV-positive patients with and without lesion showed that they had similar clinical characteristics, except for gender and viral load values that showed statistically significant differences (Table 2 ). There was a predominance of male patients with lesions (p=0.03), .5) 15 (6) 107 (45) 7 (3) 112 (46) 8 (3) 7 (3) 3 (1) 92 (38) 23 (10) 82 (34) 70 (29) 57 (23) 7 (3) 2 (1) 19 (8) 76 (31) 142 (59) 4 (2) 62 ( 
Discussion
The spread of HIV infection in Brazil has revealed an epidemic of multiple dimensions, with a significant change in the epidemiological profile over the years, following the global trend. Initially restricted to large urban centers and markedly masculine, the HIV/AIDS epidemic is currently characterized by an increase in heterosexual transmission, with a substantial increase in number of cases among women and injecting drug users, spread of disease to small and midsized cities, and pauperization of the infected population 7 . Since 1996 Brazil has provided free antiretroviral drugs to all patients with HIV/AIDS, according to a guideline for the use of antiretroviral agents in HIV-1 infected adults and adolescents. The consolidation of the care policy for people living with HIV in Brazil has produced considerably positive results. Until 2005, AIDS-related mortality rate was reduced by almost 40% and the median survival rate of people living with HIV increased from 58 months in 1995-1996 to 108 months in 1998-1999
8 . The availability of antiretroviral drugs on a large-scale has contributed to reduce the frequency and change the pattern of oral manifestations, and, thus, many complaints tended to be overlooked by healthcare professionals. Also, the causes of oral diseases in HIV-positive patients were little investigated. This study showed a higher frequency of oral lesions in HIV-positive patients compared with the control group, highlighting the importance of oral clinical examination of these patients, as well as of detection and diagnosis of HIV (16) 21 (38) 14 (25) 8 (14) 3 (5) 1 (2) 17 (30) 39 ( Table 2 . Clinical, epidemiological and demographic data from HIV-positive patients with and without oral lesions IQR -interquartile range. * -cells/mm 3 . ** -copies/mL. NI: not informed.
in patients with these symptoms by the dentist. The success or failure of antiretroviral therapy is assessed by viral load and CD4+ T lymphocytes count. Undetectable viral load indicates a strong control of viral replication and, therefore, reduced damage to the immune system 4 . This study showed that 69.3% of patients had undetectable viral load, which shows the success of therapy in most patients.
Of all the patients with oral lesions, 80% (45/56) were on regular treatment and 20% (11/56) were not on HAART. In both groups, periodontal changes were the most common lesions followed by oral candidiasis and idiopathic white patch or leukoplakia, which is an area of keratosis that appears as adherent white spots on the mucous membranes of the oral cavity. It consists predominantly in white lesion of the oral mucosa that cannot be characterized as any other definable lesion. Therefore, there was no statistical difference in the prevalence of oral manifestations or in the distribution of lesions between patients on HAART and those not on HAART. The prevalence of oral lesions in untreated patients was similar to that found previously 6 , which showed that 20% of patients not on HAART had some type of oral lesion.
Likewise, Nittayananta et al. 9 (2002) showed that hyperpigmentation was a very frequent lesion in patients using HAART, which was considered a consequence of zidovudine use, and compared with patients not on HAART, patients on HAART were at lower risk of caries and periodontal disease. In this study, the frequency of periodontal changes was similar in both groups, regardless of drug use.
Despite the advances represented by antiretroviral drugs, their serious side-effects may reduce the levels of patient adherence to treatment. These effects may also be associated with oral manifestations, such as sore throat, dry mouth and perioral paresthesia 5 , such findings were not observed in this study group.
HIV-positive patients may have decrease in the salivary flow, which can result from the viral infection or be a side effect of antiretroviral therapy. Thus, these patients may show higher caries prevalence, higher rates of periodontal disease, mucositis and opportunistic infections, as well as salivary gland lesions, that signs include swollen glands and a decrease in salivation 5 . Candidiasis was the most prevalent oral manifestation in HIV-positive patients compared with the control group, 29% and 20%, respectively. This infection has been widely associated with HIV infection and was present in all the reviewed articles on the prevalence of oral manifestations in these patients 10 . According to Shirlaw et al. 11 (2002) candidiasis occurs in 50% of HIV-infected individuals and 90% of those with AIDS. In asymptomatic HIV-infected individuals it is a sign of immunosuppression and often precedes the transition to AIDS 12 . Periodontal disease (PD) is an inflammatory and chronic bacterial disease, which initially affects the gingival tissues. Over time, it can lead to destruction of the tissues that support the teeth. The presence of periodontal involvement (gingivitis, periodontitis, acute necrotizing ulcerative gingivitis -ANUG and acute necrotizing ulcerative periodontitis -ANUP) is an indication that the individual's immune system is impaired, and its early recognition may impact HIV-positive patients' life quality.
Several studies show that the clinical course of chronic periodontitis is faster in HIV/AIDS patients compared with HIV-negative individuals. HIV/AIDS patients have subgingival microorganisms similar to those found in periodontal pockets of HIV-negative individuals. However, in HIV/AIDS patients there is also the presence of other opportunistic microorganism unrelated to chronic periodontitis, which may be related to the rapid development of periodontal disease. Another possible cause of periodontal destruction in HIV patients may be the increased activity of periodontal disease, as a consequence of the high levels of proinflammatory cytokines in the gingival crevicular fluid from sites with active periodontal disease 13 . In this study, periodontal changes were found in 25% of the cases, while none were found in the control group. Of those patients, approximately 40% had current CD4+ T cells counts between 200 and 500 cells/mm 3 and 46% had undetectable viral load. Mariano 14 did not find significant differences between cases and controls. Similarly, other authors did not find a direct relationship between the degree of immunosuppression by HIV and the prevalence of periodontal disease, since most patients with severe periodontal disease were HIV asymptomatic 15 . These findings were also consistent with the study conducted by Scheutz et al. 16 (1997) and Vastardis, et al. 17 (2003) , who did not find correlation between CD4+T cells count and severe periodontal disease.
Laskaris, Madjivassilion and Stratigos 18 (1992) reported the difficulty of correlating periodontal disease with HIV infection, since most patients showed poor oral hygiene, high incidence of dental biofilms, often causing gingivitis and periodontitis. No significant difference was observed regarding tooth cleaning frequency between the groups. Therefore, this factor would probably not have influenced these findings.
In this study, herpes simplex infection in the lower lip was more common in control group (80%) than in HIVpositive patients (3.5%), similarly to Chagas, Santos and Ulcerations in the oral mucosa that are related to the immune status of the patient are observed in HIV-positive patients 23 . Mouth ulcers are reported in several studies in HIV-infected individuals, with variations in prevalence as seen in India (3.8%) 20 , China (14.8%) 24 and England (23%) 25 . In the present study, approximately 5% of the patients had such oral lesions, which is similar to the 7% found in the study of Chagas, Santos and Ono 2 (2009). The wide availability of HAART had a major impact on improving survival of HIV-positive patients. Moreover, a change could be seen in the pattern of the clinical disease in this group of patients. A decrease of frequency of some diseases, such as Kaposi's sarcoma was observed, but current findings demonstrate that HIV-positive patients, regardless of their response to therapy, have an increased frequency of other oral lesions, such as periodontal disease, compared with uninfected individuals 26 . These data reinforce the need for periodic dental evaluation. It should be included in the routine monitoring of these patients, as well as the early referral of patients with these oral lesions to specialist care.
In conclusion, after the introduction of HAART there was a significant decrease in the frequency of oral lesions on HIV+ patients. However, this study shows a high prevalence of other common oral lesions in HIV/AIDS patients in comparison with individuals not carrying the virus, such as periodontal diseases and candidiasis. It reinforces the need of a multidisciplinary approach of HIV/AIDS patients attending specialized centers that include regular dental evaluations aiming at early detection of diseases and prompt treatment, contributing to a better quality of life for these patients.
